In 2022, tuberculosis (TB) was the second-leading cause of global deaths from a single infectious agent. Delays in initiating TB treatment can lead to increased morbidity and mortality.Read More
Tuberculosis remains a global health concern, and half of cured patients have permanent lung injury. N-acetylcysteine (NAC) has shown beneficial antimicrobial, antioxidant, and immunomodulatory effects in preclinical tuberculosis models. We examined its effects on tuberculosis treatment outcomes.Read More
Learn about the post-TB burden, challenges faced by TB patients and survivors, and the crucial role of civil society in addressing the post-TB long-term (lung) consequences. This webinar will provide valuable insights for healthcare professionals, researchers, policymakers, and anyone interested in TB impact.Read More
After two years of online meetings and video calls, it was exciting to have the TB Sequel annual meeting in-person in Magaliesburg, South Africa in March this year. This meeting was attended by 42 people representing the research and co-ordinating teams from the participating TB Sequel sites.Read More
After two years of online meetings and video calls, it was exciting to have the TB Sequel annual meeting in-person in Magaliesburg, South Africa in March this year. This meeting was attended by 42 people representing the research and co-ordinating teams from the participating TB Sequel sites.Read More
Stakeholders’ workshop on the use of digital platforms for research data management and sharing in sub-Saharan Africa CYSTINET-Africa, TAKeOFF, and TB Sequel projects, through the support from, the German Federal Ministry of Education and Research under the CYSTINET-Africa, organized a collaborative initiative to explore the use of digital platforms for early translation of health research findings in...Read More
Due to the current epidemic, the TB Sequel team came together for a virtual scientific meeting on the 22 – 23 July. Baseline findings were presented and discussed for each Research task. Masters and PhD students had the opportunity to present their work. Fruitful discussion also included brainstorming the future of TB Sequel in 2022...Read More
The world has taken on a new normal with the COVID-19 pandemic. We find ourselves practicing social distancing and wearing face masks when around others. Amidst COVID-19, we still have TB that we are battling around the world. TB Sequel principal investigators and study coordination teams are closely monitoring the COVID-19 health situation at the...Read More
Members of the TB Sequel team attended the Research Networks for Health Innovations in Sub-Saharan Africa mid- term meeting which took place from the 28th to the 31st of January 2020 in Accra, Ghana. The team took part in facilitating some of the workshops held during the meetings and some of the TB Sequel students displayed posters...Read More
We are very happy to announce that we have reached a milestone in the TB Sequel project. Enrolments into the cohort are complete and we have reached 1509 participants across all four sites. Enrollment into the NAC Research Task 5 in Tanzania is still ongoing. A huge thank you to the TB Sequel team for...Read More
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
cookielawinfo-checkbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
